- Home
- C vs BSX Comparison
C vs BSX Comparison
Compare C & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- C
- BSX
- Stock Information
- Founded
- C 1812
- BSX 1979
- Country
- C United States
- BSX United States
- Employees
- C N/A
- BSX N/A
- Industry
- C Major Banks
- BSX Medical/Dental Instruments
- Sector
- C Finance
- BSX Health Care
- Exchange
- C Nasdaq
- BSX Nasdaq
- Market Cap
- C 176.2B
- BSX 157.6B
- IPO Year
- C N/A
- BSX 1992
- Fundamental
- Price
- C $95.80
- BSX $97.21
- Analyst Decision
- C Buy
- BSX Strong Buy
- Analyst Count
- C 15
- BSX 22
- Target Price
- C $98.83
- BSX $121.09
- AVG Volume (30 Days)
- C 12.6M
- BSX 12.1M
- Earning Date
- C 10-14-2025
- BSX 10-22-2025
- Dividend Yield
- C 2.50%
- BSX N/A
- EPS Growth
- C 87.24
- BSX 36.90
- EPS
- C 6.76
- BSX 1.68
- Revenue
- C $72,825,000,000.00
- BSX $18,494,000,000.00
- Revenue This Year
- C $21.13
- BSX $19.85
- Revenue Next Year
- C $3.00
- BSX $11.07
- P/E Ratio
- C $14.20
- BSX $57.90
- Revenue Growth
- C 4.78
- BSX 21.44
- 52 Week Low
- C $55.51
- BSX $80.64
- 52 Week High
- C $105.59
- BSX $109.50
- Technical
- Relative Strength Index (RSI)
- C 40.71
- BSX 39.59
- Support Level
- C $96.70
- BSX $95.38
- Resistance Level
- C $100.06
- BSX $98.48
- Average True Range (ATR)
- C 2.34
- BSX 2.32
- MACD
- C -0.95
- BSX 0.11
- Stochastic Oscillator
- C 2.86
- BSX 69.44
About C Citigroup Inc.
Citigroup is a global financial-services company doing business in more than 100 countries and jurisdictions. Citigroup's operations are organized into five primary segments: services, markets, banking, US personal banking, and wealth management. The bank's primary services include cross-border banking needs for multinational corporates, investment banking and trading, and credit card services in the United States.
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.